Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of reduced ritonavir dose in HIV patients on tipranavir/ritonavir
2007-004825-35Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ritonavir in human immunodeficiency virus infection (HIV), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: Virologic suppression at 24 weeks. Started Oct 2007; status: completed.
02
Drugs
ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-004825-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004825-35.